MediWound Ltd.

Healthcare · Biotechnology · Israel

Last price 13.3 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 171.71M

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

MediWound Ltd., a biopharmaceutical company, develops, manufactures, and commercializes novel, bio-therapeutic, and non-surgical solutions for tissue repair and regeneration in the United States, Germany, Italy, Spain, and internationally. The company markets NexoBrid, a biopharmaceutical product for the removal of eschar in patients with deep partial- and full-thickness thermal burns to burn centers and hospitals burn units. It also develops EscharEx, a bromelain-based, bioactive enzymatic therapy for the treatment of chronic wounds and other ...